Youngest Cedars-Sinai Stem Cell Donor Helps Doctors Treat Dad’s Leukemia

by admin | Sep 25, 2025 | News & Opinions

By Cedars Sinai – In July, Nick Mondek, MD, drove his healthy 9-year-old son Stephen to Cedars-Sinai on an important mission: To donate stem cells that might cure Mondek’s deadly blood cancer. Stephen’s donation would give Mondek a brand-new immune system—and...

New stem cell approach could repair stroke-damaged brains

by admin | Sep 24, 2025 | News & Opinions

by Drug Target Review – A new experimental stem cell therapy shows promise in repairing brain damage after ischemic strokes – potentially allowing for the development of future treatments that extend the recovery window. Strokes are a leading worldwide cause of...

CAR T’s biggest hurdle: solving the toxicity problem

by admin | Sep 23, 2025 | News & Opinions

By Drug Target Review – CAR T therapies are saving lives, but toxicities such as CRS and ICANS remain a major barrier. What will it take to overcome them? Chimeric antigen receptor (CAR) T-cell therapy is changing lives for patients with hard-to-treat cancers....

Evaluating the long-term efficacy of umbilical cord-derived mesenchymal stem cell therapy in retinitis pigmentosa: findings from a 1-to-4-year follow-up

by admin | Sep 22, 2025 | News & Opinions

By Stem Cells Translational Medicine – Background The objective of this study was to assess the long-term effectiveness and safety of implanting mesenchymal stem cells derived from umbilical cord tissue (UC-MSC) in patients diagnosed with retinitis pigmentosa...

New AI Tool Pinpoints Genes, Drug Combos To Restore Health in Diseased Cells

by admin | Sep 19, 2025 | News & Opinions

By Ekaterina Pesheva – Harvard Medical School – New AI tool accurately identifies multiple drivers of disease in cells and predicts therapies that can restore cells to healthy function. In a move that could reshape drug discovery, researchers at Harvard...